FORME (Nasdaq:TRNR) Just Completed an IPO and Could Become The Next Powerhouse In The At-Home Fitness Industry with a Differentiated...
Read moreDetailsGlobally renowned serial entrepreneur with over two decades of experience in executing disruptive approaches to a wide range of industries...
Read moreDetailsTiziana Life Sciences Ltd is a biotechnology company focused on discovering and developing molecules for the treatment of human diseases...
Read moreDetailsBrüush Oral Care, Inc. (NASDAQ: BRSH) is an exciting oral care-based subscription service offering sleekly designed electric toothbrushes at a...
Read moreDetailsOKYO Pharma's main drug has already surpassed Phase 1 and reached Phase 2. OK-101 is catering to niches within the...
Read moreDetailsAmesite, a Michigan-based EdTech company, has announced that it will be integrating OpenAI's GPT-3 technology into its platform. This integration...
Read moreDetailsSharps Technology Inc. is a medical technology company examining, designing, developing, manufacturing, distributing, and selling safety syringe products in both...
Read moreDetailsInnovaQor is a Florida-based technology small-cap catering healthcare and laboratory customers in the U.S. with information technology solutions and services.
Read moreDetailsInnovaQor Inc. is an emerging company in the healthcare IT industry and offers a wide range of information technology services...
Read moreDetailsThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.